HealthCap is a life science investor and company creator that invests in people and companies that could influence healthcare and society.

Aerocrine announced an exclusive agreement with Intramedic AB to distribute its NIOX VERO airway inflammation monitor and test kit in Sweden.

Oncopeptides published its second-quarter 2025 report. CEO Sofia Heigis said sales had grown more than 30% quarter over quarter for the third consecutive quarter.

Orexo announced that its sponsored Level 1 American Depositary Receipt program in the United States was fully implemented, with the ADRs trading on the OTC market under the symbol ORXOY.

The HealthCap team has experience in medicine, pharmacology, engineering, law, and related professions.

HealthCap is a European venture capital firm investing globally in life sciences. Since 1996, it has raised nine funds, backed or built more than 130 companies, taken more than 45 companies public, and completed trade sales.

HealthCap says its strategy is to build a long-term venture capital business in life sciences, focusing on breakthrough therapies that provide value to stakeholders.

HealthCap is a European venture capital firm that invests globally and exclusively in life sciences. Its investment objective is capital appreciation through developing therapies for diseases with significant unmet medical needs, and it is a signatory to the Principles for Responsible Investment.

HealthCap is a life science investor and company creator that seeks ideas and investments that could impact healthcare and society.

The page defines a cookie as a data file, often containing a unique identifier, sent from a web server to a browser and stored on the browsing device.

Odlander, Fredrikson & Co AB owns and operates healthcap.eu; the privacy notice refers to the company as HealthCap.